Cargando…

Madecassic Acid—A New Scaffold for Highly Cytotoxic Agents

Due to their manifold biological activities, natural products such as triterpenoids have advanced to represent excellent leading structures for the development of new drugs. For this reason, we focused on the syntheses and cytotoxic evaluation of derivatives obtained from gypsogenin, hederagenin, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kraft, Oliver, Hartmann, Ann-Kathrin, Hoenke, Sophie, Serbian, Immo, Csuk, René
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026082/
https://www.ncbi.nlm.nih.gov/pubmed/35457180
http://dx.doi.org/10.3390/ijms23084362
_version_ 1784691036149252096
author Kraft, Oliver
Hartmann, Ann-Kathrin
Hoenke, Sophie
Serbian, Immo
Csuk, René
author_facet Kraft, Oliver
Hartmann, Ann-Kathrin
Hoenke, Sophie
Serbian, Immo
Csuk, René
author_sort Kraft, Oliver
collection PubMed
description Due to their manifold biological activities, natural products such as triterpenoids have advanced to represent excellent leading structures for the development of new drugs. For this reason, we focused on the syntheses and cytotoxic evaluation of derivatives obtained from gypsogenin, hederagenin, and madecassic acid, cytotoxicity increased—by and large—from the parent compounds to their acetates. Another increase in cytotoxicity was observed for the acetylated amides (phenyl, benzyl, piperazinyl, and homopiperazinyl), but a superior cytotoxicity was observed for the corresponding rhodamine B conjugates derived from the (homo)-piperazinyl amides. In particular, a madecassic acid homopiperazinyl rhodamine B conjugate 24 held excellent cytotoxicity and selectivity for several human tumor cell lines. Thus, this compound was more than 10,000 times more cytotoxic than parent madecassic acid for A2780 ovarian cancer cells. We assume that the presence of an additional hydroxyl group at position C–6 in derivatives of madecassic, as well as the (2α, 3β) configuration of the acetates in ring A, had a beneficial effect onto the cytotoxicity of the conjugates, as well as onto tumor/non-tumor cell selectivity.
format Online
Article
Text
id pubmed-9026082
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90260822022-04-23 Madecassic Acid—A New Scaffold for Highly Cytotoxic Agents Kraft, Oliver Hartmann, Ann-Kathrin Hoenke, Sophie Serbian, Immo Csuk, René Int J Mol Sci Article Due to their manifold biological activities, natural products such as triterpenoids have advanced to represent excellent leading structures for the development of new drugs. For this reason, we focused on the syntheses and cytotoxic evaluation of derivatives obtained from gypsogenin, hederagenin, and madecassic acid, cytotoxicity increased—by and large—from the parent compounds to their acetates. Another increase in cytotoxicity was observed for the acetylated amides (phenyl, benzyl, piperazinyl, and homopiperazinyl), but a superior cytotoxicity was observed for the corresponding rhodamine B conjugates derived from the (homo)-piperazinyl amides. In particular, a madecassic acid homopiperazinyl rhodamine B conjugate 24 held excellent cytotoxicity and selectivity for several human tumor cell lines. Thus, this compound was more than 10,000 times more cytotoxic than parent madecassic acid for A2780 ovarian cancer cells. We assume that the presence of an additional hydroxyl group at position C–6 in derivatives of madecassic, as well as the (2α, 3β) configuration of the acetates in ring A, had a beneficial effect onto the cytotoxicity of the conjugates, as well as onto tumor/non-tumor cell selectivity. MDPI 2022-04-14 /pmc/articles/PMC9026082/ /pubmed/35457180 http://dx.doi.org/10.3390/ijms23084362 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kraft, Oliver
Hartmann, Ann-Kathrin
Hoenke, Sophie
Serbian, Immo
Csuk, René
Madecassic Acid—A New Scaffold for Highly Cytotoxic Agents
title Madecassic Acid—A New Scaffold for Highly Cytotoxic Agents
title_full Madecassic Acid—A New Scaffold for Highly Cytotoxic Agents
title_fullStr Madecassic Acid—A New Scaffold for Highly Cytotoxic Agents
title_full_unstemmed Madecassic Acid—A New Scaffold for Highly Cytotoxic Agents
title_short Madecassic Acid—A New Scaffold for Highly Cytotoxic Agents
title_sort madecassic acid—a new scaffold for highly cytotoxic agents
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026082/
https://www.ncbi.nlm.nih.gov/pubmed/35457180
http://dx.doi.org/10.3390/ijms23084362
work_keys_str_mv AT kraftoliver madecassicacidanewscaffoldforhighlycytotoxicagents
AT hartmannannkathrin madecassicacidanewscaffoldforhighlycytotoxicagents
AT hoenkesophie madecassicacidanewscaffoldforhighlycytotoxicagents
AT serbianimmo madecassicacidanewscaffoldforhighlycytotoxicagents
AT csukrene madecassicacidanewscaffoldforhighlycytotoxicagents